Assessment of Antioxidant Effect of Beta-Glucan on the Whole Blood Oxidative DNA Damage with the Comet Assay in Colorectal Cancer.


Journal

Current molecular pharmacology
ISSN: 1874-4702
Titre abrégé: Curr Mol Pharmacol
Pays: United Arab Emirates
ID NLM: 101467997

Informations de publication

Date de publication:
2022
Historique:
received: 20 09 2020
revised: 10 12 2020
accepted: 12 01 2021
pubmed: 20 2 2021
medline: 25 5 2022
entrez: 19 2 2021
Statut: ppublish

Résumé

The present study aims to evaluate the antioxidant effect of beta-glucan on oxidative DNA damage by comet assay. A total of 19 adult females and males diagnosed with stage 3-4 colorectal cancer and a control group of 20 age-matched healthy subjects were enrolled in the study. Blood samples of the participants were analyzed using Comet Assay for the parameters of DNA damage. Significantly increased DNA damage was observed in patients versus the control group as indicated by greater values of tail moment, tail percent DNA and tail length. Following incubation with β-glucan, a substantial reduction was found in the aforementioned parameters of DNA damage. Comet assay revealed significant levels of endogenous DNA damage in patients as shown by remarkable increases in the tail moment, the percentage of DNA in the tail and the tail length values, in comparison with the control group. Following treatment of fresh whole blood with β-glucan incubation, DNA damages were significantly reduced, but lower values were observed after β-glucan incubation in the patient group versus control group. β-Glucan was found to reduce DNA damage substantially in colorectal cancer patients and show antimutagenic effects. Our results suggested that dietary β-glucan intake might be important in the genesis of colorectal cancer tumors.

Identifiants

pubmed: 33605867
pii: CMP-EPUB-114398
doi: 10.2174/1874467214666210219145445
doi:

Substances chimiques

Antioxidants 0
beta-Glucans 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

446-453

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Necla Benlier (N)

Department of Medical Pharmacology, SANKO University School of Medicine, 27090, Gaziantep, Turkey.

Nilay Uçar (N)

Department of Molecular Medicine, SANKO University Graduate Institute of Education, 27090, Gaziantep, Turkey.

Eda Öğüt (E)

Department of Medical Biochemistry, SANKO University School of Medicine, 27090, Gaziantep, Turkey.

Havva Yeşil Çinkir (HY)

Department of Internal Medicine, Gaziantep University School of Medicine, 27090, Gaziantep, Turkey.

Mustafa Yildirim (M)

Department of Internal Medicine, Bahçeşehir University School of Medicine, Beşiktaş 34353, Istanbul, Turkey.

Pınar Günel Karadeniz (PG)

Department of Biostatistics, SANKO University Faculty of Medicine, 27090, Gaziantep, Turkey.

Esra Küpeli Akkol (EK)

Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler 06330, Ankara, Turkey.

Haroon Khan (H)

Department of Pharmacy, Abdul Wali Khan University Mardan, 23200, Mardan, Pakistan.

Eyüp Ilker Saygili (EI)

Department of Molecular Medicine, SANKO University Graduate Institute of Education, 27090, Gaziantep, Turkey.
Department of Medical Biochemistry, SANKO University School of Medicine, 27090, Gaziantep, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH